FDA Dispute Resolution Rules May Not Supplant Informal Appeals - Morrison
Executive Summary
Industry continues to exercise informal appeals rather than official dispute resolution procedures to address disagreements with FDA, Center for Drug Evaluation & Research Ombudsman Jim Morrison said.